Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Drug Discovery: Overview01:26

Drug Discovery: Overview

12.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.2K
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

34
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
34
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

23
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
23
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

27
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
27
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.3K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

GluD1 is localized at cholinergic synapses and is an acetylcholine receptor.

Molecular psychiatry·2026
Same author

A Molecular Playground for Spin-State Ice and Coupled Electron-Spin Dynamics.

Journal of the American Chemical Society·2026
Same author

Three-dimensional printing of multilayer stretchable electronics with inclined interconnect accesses.

Nature communications·2026
Same author

Development and validation of a machine learning-based model for assessing coronary artery disease risk in postmenopausal women: a dual-center retrospective study.

Nan fang yi ke da xue xue bao = Journal of Southern Medical University·2026
Same author

Building a SHAP interpretable prediction model for stroke-associated pneumonia [stroke-associated pneumonia (SAP)] in patients with aneurysmal subarachnoid hemorrhage (aSAH).

Frontiers in neurology·2026
Same author

A Fine-Tuned Multimodal AI Chatbot for Dietary Health and Nutrition, Purrfessor: Development and Mixed Methods Evaluation.

JMIR AI·2026
Same journal

VideoPASTA: 7K Preference Pairs That Matter for Video-LLM Alignment.

Proceedings of the Conference on Empirical Methods in Natural Language Processing. Conference on Empirical Methods in Natural Language Processing·2026
Same journal

Synth-SBDH: A Synthetic Dataset of Social and Behavioral Determinants of Health for Clinical Text.

Proceedings of the Conference on Empirical Methods in Natural Language Processing. Conference on Empirical Methods in Natural Language Processing·2026
Same journal

X-CoT: Explainable Text-to-Video Retrieval via LLM-based Chain-of-Thought Reasoning.

Proceedings of the Conference on Empirical Methods in Natural Language Processing. Conference on Empirical Methods in Natural Language Processing·2026
Same journal

DischargeSim: A Simulation Benchmark for Educational Doctor-Patient Communication at Discharge.

Proceedings of the Conference on Empirical Methods in Natural Language Processing. Conference on Empirical Methods in Natural Language Processing·2026
Same journal

From Scores to Steps: Diagnosing and Improving LLM Performance in Evidence-Based Medical Calculations.

Proceedings of the Conference on Empirical Methods in Natural Language Processing. Conference on Empirical Methods in Natural Language Processing·2026
Same journal

BMRetriever: Tuning Large Language Models as Better Biomedical Text Retrievers.

Proceedings of the Conference on Empirical Methods in Natural Language Processing. Conference on Empirical Methods in Natural Language Processing·2026
查看所有相关文章

相关实验视频

Updated: Feb 24, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.6K

Assay2Mol:基于大型语言模型的药物设计,使用生物测试环境.

Yifan Deng1,2, Spencer S Ericksen3, Anthony Gitter1,2,4

  • 1Department of Computer Sciences, University of Wisconsin-Madison.

Proceedings of the Conference on Empirical Methods in Natural Language Processing. Conference on Empirical Methods in Natural Language Processing
|February 23, 2026
PubMed
概括
此摘要是机器生成的。

Assay2Mol,一个新的工作流程,解锁生物化学查数据用于药物发现. 它通过从现有测试信息中学习来产生新药候选者,优于其他方法.

更多相关视频

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.7K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.6K

相关实验视频

Last Updated: Feb 24, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.6K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.7K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.6K

科学领域:

  • 生物化学 生物化学
  • 计算机化药物发现.
  • 生物信息学是一种生物信息学.

背景情况:

  • 科学数据库包含大量的定量和文本数据.
  • 生物化学测定选分子对抗疾病点.
  • 测试中的非结构化文本包含有价值的药物发现信息.
  • 由于其格式,这些信息在很大程度上未被利用.

研究的目的:

  • 为了介绍Assay2Mol,一个基于大型语言模型的工作流.
  • 为了利用现有的生物化学查试验,用于早期药物发现.
  • 释放非结构化测试数据的潜力.

主要方法:

  • Assay2Mol使用了一个大型语言模型.
  • 它可以检索类似目标的现有测试记录.
  • 它通过从检索的数据中使用上下文学习生成候选分子.

主要成果:

  • Assay2Mol的表现优于最近的机器学习方法.
  • 它有效地产生候选配体分子用于目标蛋白质结构.
  • 工作流促进生成更容易合成的分子.

结论:

  • Assay2Mol利用了现有的生物化学查试验.
  • 它为早期药物发现提供了一种新的方法.
  • 该方法增强了可行的候选药物的生成.